Company / Goodwill
Amphstar Pharmaceuticals, Inc. Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$3.4M
FY2025
5-year range
$3.0M / $3.4M
FY2021-FY2025
Trend
+11.6%
vs FY2024
Sector context
#65 of 74
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s goodwill of $3M is lower than 88% of companies in the Health Care sector (FY2025). Goodwill has fluctuated over the past 10 years, ranging from $3M in FY2024 to $4M in FY2017.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -2.9%.
Improved from $3M to $3M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +2.9%
- 5-Year CAGR
- -2.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 74This company $3.4M Sector average $4.0B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.9%, indicating a declining trend.
- In FY2025, goodwill increased 11.6% year-over-year.
- Ranks #65 out of 74 companies in the Health Care sector.
- Peak goodwill was recorded in FY2017.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.4M | +11.6% |
| FY2024 | $3.0M | -5.2% |
| FY2023 | $3.2M | +2.9% |
| FY2022 | $3.1M | -5.6% |
| FY2021 | $3.3M | -15.9% |
| FY2020 | $3.9M | +8.4% |
| FY2019 | $3.6M | -8.0% |
| FY2018 | $4.0M | -11.4% |
| FY2017 | $4.5M | +12.2% |
| FY2016 | $4.0M | +6.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026